Discontinued — last reported Q4 '20
Investing
Business Sale Proceeds
Xylem Business Sale Proceeds decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $48.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows an upward trend with a 48.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2020
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $0.00 | $8.00M | $1.00M | $0.00 | $0.00 | $0.00 | $0.00 | $91.00M | $12.00M | $2.00M | $11.00M | $0.00 | $0.00 | $0.00 | $48.00M | $2.00M | -$2.00M | $1.00M | $0.00 |
| QoQ Change | — | -100.0% | — | -87.5% | -100.0% | — | — | — | — | -86.8% | -83.3% | +450.0% | -100.0% | — | — | — | -95.8% | -200.0% | +150.0% | -100.0% |
| YoY Change | — | — | — | — | -100.0% | — | -100.0% | -100.0% | — | — | — | — | -100.0% | -100.0% | -100.0% | +336.4% | — | — | — | -100.0% |
Range-$2.00M – $91.00M
CAGR-100.0%
Avg YoY Growth-45.5%
Median YoY Growth-100.0%
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is Xylem's business sale proceeds?
- Xylem (XYL) reported business sale proceeds of $0.00 in Q1 2026.
- How has Xylem's business sale proceeds changed year-over-year?
- Xylem's business sale proceeds decreased by 100.0% year-over-year, from $48.00M to $0.00.
- What is the long-term trend for Xylem's business sale proceeds?
- Over 4 years (2021 to 2025), Xylem's business sale proceeds has grown at a 48.8% compound annual growth rate (CAGR), from $10.00M to $49.00M.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.